These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Membrane Active Small Molecules Show Selective Broad Spectrum Antibacterial Activity with No Detectable Resistance and Eradicate Biofilms. Hoque J; Konai MM; Gonuguntla S; Manjunath GB; Samaddar S; Yarlagadda V; Haldar J J Med Chem; 2015 Jul; 58(14):5486-500. PubMed ID: 26102297 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria. Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378 [TBL] [Abstract][Full Text] [Related]
5. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
6. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909 [TBL] [Abstract][Full Text] [Related]
8. Lysine-Based Small Molecules That Disrupt Biofilms and Kill both Actively Growing Planktonic and Nondividing Stationary Phase Bacteria. Konai MM; Haldar J ACS Infect Dis; 2015 Oct; 1(10):469-78. PubMed ID: 27623313 [TBL] [Abstract][Full Text] [Related]
9. Small molecular antibacterial peptoid mimics: the simpler the better! Ghosh C; Manjunath GB; Akkapeddi P; Yarlagadda V; Hoque J; Uppu DS; Konai MM; Haldar J J Med Chem; 2014 Feb; 57(4):1428-36. PubMed ID: 24479371 [TBL] [Abstract][Full Text] [Related]
10. Neopyrrolomycins with broad spectrum antibacterial activity. Hopp DC; Rhea J; Jacobsen D; Romari K; Smith C; Rabenstein J; Irigoyen M; Clarke M; Francis L; Luche M; Carr GJ; Mocek U J Nat Prod; 2009 Feb; 72(2):276-9. PubMed ID: 19191549 [TBL] [Abstract][Full Text] [Related]
11. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance. Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484 [TBL] [Abstract][Full Text] [Related]
12. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269 [TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study. Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822 [TBL] [Abstract][Full Text] [Related]
14. A multivalent approach to drug discovery for novel antibiotics. Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antibacterial activity of spermidine-based mixed catechol- and hydroxamate-containing siderophore--vancomycin conjugates. Ghosh M; Miller MJ Bioorg Med Chem; 1996 Jan; 4(1):43-8. PubMed ID: 8689237 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial evaluation of novel 8-fluoro Norfloxacin derivatives as potential probes for methicillin and vancomycin-resistant Staphylococcus aureus. Sunduru N; Gupta L; Chauhan K; Mishra NN; Shukla PK; Chauhan PM Eur J Med Chem; 2011 Apr; 46(4):1232-44. PubMed ID: 21345548 [TBL] [Abstract][Full Text] [Related]
17. Potent antibacterial activity of halogenated compounds against antibiotic-resistant bacteria. Vairappan CS; Kawamoto T; Miwa H; Suzuki M Planta Med; 2004 Nov; 70(11):1087-90. PubMed ID: 15549668 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel protein synthesis inhibitor active against gram-positive bacteria. Eibergen NR; Im I; Patel NY; Hergenrother PJ Chembiochem; 2012 Mar; 13(4):574-83, 490. PubMed ID: 22362659 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, anti-MRSA, and anti-VRE activity of hemin conjugates with amino acids and branched peptides. Okorochenkov SA; Zheltukhina GA; Mirchink EP; Isakova EB; Feofanov AV; Nebolsin VE Chem Biol Drug Des; 2013 Oct; 82(4):410-7. PubMed ID: 23663365 [TBL] [Abstract][Full Text] [Related]
20. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections]. Li JT; Li Y; Wang J; Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]